BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9057652)

  • 1. Erythropoietin-induced activation of STAT5 is impaired in the myelodysplastic syndrome.
    Hoefsloot LH; van Amelsvoort MP; Broeders LC; van der Plas DC; van Lom K; Hoogerbrugge H; Touw IP; Löwenberg B
    Blood; 1997 Mar; 89(5):1690-700. PubMed ID: 9057652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unregulated activation of STAT-5, ERK1/2 and c-Fos may contribute to the phenotypic transformation from myelodysplastic syndrome to acute leukaemia.
    Kolonics A; Apáti A; Nahajevszky S; Gáti R; Brózik A; Magócsi M
    Haematologia (Budap); 2001; 31(2):125-38. PubMed ID: 11583024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel mechanism of cooperation between c-Kit and erythropoietin receptor. Stem cell factor induces the expression of Stat5 and erythropoietin receptor, resulting in efficient proliferation and survival by erythropoietin.
    Kapur R; Zhang L
    J Biol Chem; 2001 Jan; 276(2):1099-106. PubMed ID: 11042182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythropoietin stimulates proliferation and interferes with differentiation of myoblasts.
    Ogilvie M; Yu X; Nicolas-Metral V; Pulido SM; Liu C; Ruegg UT; Noguchi CT
    J Biol Chem; 2000 Dec; 275(50):39754-61. PubMed ID: 10995753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoietin-induced erythroid differentiation of the human erythroleukemia cell line TF-1 correlates with impaired STAT5 activation.
    Chrétien S; Varlet P; Verdier F; Gobert S; Cartron JP; Gisselbrecht S; Mayeux P; Lacombe C
    EMBO J; 1996 Aug; 15(16):4174-81. PubMed ID: 8861946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro proliferation and differentiation of erythroid progenitors from patients with myelodysplastic syndromes: evidence for Fas-dependent apoptosis.
    Claessens YE; Bouscary D; Dupont JM; Picard F; Melle J; Gisselbrecht S; Lacombe C; Dreyfus F; Mayeux P; Fontenay-Roupie M
    Blood; 2002 Mar; 99(5):1594-601. PubMed ID: 11861273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hematopoietic cell phosphatase negatively regulates erythropoietin-induced hemoglobinization in erythroleukemic SKT6 cells.
    Sharlow ER; Pacifici R; Crouse J; Batac J; Todokoro K; Wojchowski DM
    Blood; 1997 Sep; 90(6):2175-87. PubMed ID: 9310468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythropoietin can induce the expression of bcl-x(L) through Stat5 in erythropoietin-dependent progenitor cell lines.
    Silva M; Benito A; Sanz C; Prosper F; Ekhterae D; Nuñez G; Fernandez-Luna JL
    J Biol Chem; 1999 Aug; 274(32):22165-9. PubMed ID: 10428780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epo-induced hemoglobinization of SKT6 cells is mediated by minimal cytoplasmic domains of the Epo or prolactin receptors without modulation of GATA-1 or EKLF.
    Reese TT; Gregory RC; Sharlow ER; Pacifici RE; Crouse JA; Todokoro K; Wojchowski DM
    Growth Factors; 1997; 14(2-3):161-76. PubMed ID: 9255607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythropoiesis in myelodysplastic syndrome: expression of receptors for erythropoietin and kit ligand.
    Backx B; Broeders L; Hoefsloot LH; Wognum B; Löwenberg B
    Leukemia; 1996 Mar; 10(3):466-72. PubMed ID: 8642863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Src directly tyrosine-phosphorylates STAT5 on its activation site and is involved in erythropoietin-induced signaling pathway.
    Okutani Y; Kitanaka A; Tanaka T; Kamano H; Ohnishi H; Kubota Y; Ishida T; Takahara J
    Oncogene; 2001 Oct; 20(45):6643-50. PubMed ID: 11641791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ineffective erythropoiesis in myelodysplastic syndromes: correlation with Fas expression but not with lack of erythropoietin receptor signal transduction.
    Fontenay-Roupie M; Bouscary D; Guesnu M; Picard F; Melle J; Lacombe C; Gisselbrecht S; Mayeux P; Dreyfus F
    Br J Haematol; 1999 Aug; 106(2):464-73. PubMed ID: 10460607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A possible involvement of Stat5 in erythropoietin-induced hemoglobin synthesis.
    Wakao H; Chida D; Damen JE; Krystal G; Miyajima A
    Biochem Biophys Res Commun; 1997 May; 234(1):198-205. PubMed ID: 9168989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of STAT5 during EPO-directed suppression of apoptosis.
    Bittorf T; Seiler J; Lüdtke B; Büchse T; Jaster R; Brock J
    Cell Signal; 2000 Jan; 12(1):23-30. PubMed ID: 10676844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitogen-activated protein kinase plays an essential role in the erythropoietin-dependent proliferation of CTLL-2 cells.
    Sakamoto H; Kitamura T; Yoshimura A
    J Biol Chem; 2000 Nov; 275(46):35857-62. PubMed ID: 10960479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epo regulates erythroid proliferation and differentiation through distinct signaling pathways: implication for erythropoiesis and Friend virus-induced erythroleukemia.
    Zochodne B; Truong AH; Stetler K; Higgins RR; Howard J; Dumont D; Berger SA; Ben-David Y
    Oncogene; 2000 May; 19(19):2296-304. PubMed ID: 10822380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signaling induced by erythropoietin and stem cell factor in UT-7/Epo cells: transient versus sustained proliferation.
    Erickson-Miller CL; Pelus LM; Lord KA
    Stem Cells; 2000; 18(5):366-73. PubMed ID: 11007921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythropoietin-mediated activation of JAK-STAT signaling contributes to cellular invasion in head and neck squamous cell carcinoma.
    Lai SY; Childs EE; Xi S; Coppelli FM; Gooding WE; Wells A; Ferris RL; Grandis JR
    Oncogene; 2005 Jun; 24(27):4442-9. PubMed ID: 15856028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct signal transduction abnormalities and erythropoietin response in bone marrow hematopoietic cell subpopulations of myelodysplastic syndrome patients.
    Spinelli E; Caporale R; Buchi F; Masala E; Gozzini A; Sanna A; Sassolini F; Valencia A; Bosi A; Santini V
    Clin Cancer Res; 2012 Jun; 18(11):3079-89. PubMed ID: 22496271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor-I augments erythropoietin-induced proliferation through enhanced tyrosine phosphorylation of STAT5.
    Okajima Y; Matsumura I; Nishiura T; Hashimoto K; Yoshida H; Ishikawa J; Wakao H; Yoshimura A; Kanakura Y; Tomiyama Y; Matsuzawa Y
    J Biol Chem; 1998 Sep; 273(36):22877-83. PubMed ID: 9722506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.